Dulaglutide is a GLP‐1 RA that has been shown to exert great potential for inducing weight loss in patients with Type 2 DM, particularly in cases where conventional anti‐obesity therapies have proven insufficient.7, 8, 9. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.